Foley Hoag LLP represented Alcyone Therapeutics on the deal. Alcyone Therapeutics (Alcyone) announced the negotiation of a license and collaboration agreement with Biogen Inc. (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Thermo Fisher Scientific Inc. on the acquisition. Thermo Fisher Scientific Inc. (NYSE: TMO), a world leader in serving science, has acquired Max Analytical Technologies, a...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented Thermo Fisher Scientific in the acquisition. On December 30, 2021, Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc.,...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics announced a $75 million Series C Financing. Proceeds from the Series C financing will support the...
You must be a Standard 1 Year member to access this content.
